Eversana
Eversana, officially known as Eversana Life Science Services, is a leading provider of commercial services for the life sciences industry, headquartered in the United States. Founded in 2018, the company has rapidly established itself as a key player in the healthcare sector, offering a comprehensive suite of solutions that span market access, patient support, and commercialisation strategies. With a strong presence across North America and Europe, Eversana is dedicated to enhancing patient outcomes through innovative services tailored to the unique needs of biopharmaceutical companies. Their core offerings, including integrated market access and patient engagement solutions, set them apart by ensuring that therapies reach the patients who need them most. Eversana's commitment to excellence has earned it a notable position in the market, recognised for its ability to drive efficiency and improve patient experiences in an increasingly complex healthcare landscape.
DitchCarbon Score
How does Eversana's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Eversana's score of 3 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Eversana's reported carbon emissions
Eversana, headquartered in the United States, currently does not have publicly available carbon emissions data for the most recent year. However, the company has made significant commitments towards reducing its carbon footprint. Eversana is actively engaged in setting reduction targets, with a status of "Committed" for near-term targets and "Targets Set" for long-term goals. While specific numerical targets have not been disclosed, Eversana's initiatives reflect a commitment to addressing climate change within the pharmaceuticals, biotechnology, and life sciences sector. The company has not yet committed to a net-zero target or specified a timeline for achieving such goals. Eversana's efforts are part of a broader industry trend where companies are increasingly recognising the importance of sustainability and climate action. As they continue to develop their strategies, stakeholders can expect further updates on their emissions and reduction initiatives in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Eversana is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
